Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...

Ovarian cancer kills an estimated 12,700 women annually, with around 20,000 women getting a diagnosis each year.

Researchers have developed a new prediction tool that could help clinicians better assess whether complete tumour removal is ...

Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...

CHICAGO -- Upfront surgery for advanced ovarian cancer failed to improve overall survival (OS) versus interval debulking but did improve progression-free survival (PFS) for the first time in a phase ...

The optimal timing of surgery in patients with resectable advanced ovarian cancer remains controversial. Should these patients receive the standard radical surgery followed by chemotherapy, or could ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

NACT followed by ICS significantly improves 3-year PFS and OS in advanced ovarian cancer compared to chemotherapy alone. Patients undergoing NACT and ICS had better outcomes than those receiving only ...

DANBURY, Connecticut -- Doctors at a Connecticut hospital say they removed a 132-pound tumor from a woman's abdomen, and she is expected to recover fully. The ovarian tumor was diagnosed after the ...

Robotic surgery is reshaping modern medicine. A combination of robotics and advanced imaging technologies allows surgeons to ...

CHICAGO - Known as 'the silent killer' due to its lack of symptoms and reliable screening tests, ovarian cancer remains one ...